CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Buy
70
GAN Quote, Financials, Valuation and Earnings
Last price:
$1.81
Seasonality move
:
100.2%
Day range:
$1.78 - $1.82
52-week range:
$1.18 - $1.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.62x
P/B ratio:
--
Volume:
95.9K
Avg. volume:
141.2K
1-year change:
52.1%
Market cap:
$82.9M
Revenue:
$135M
EPS (TTM):
-$0.18
Analysts' Opinion
-
Consensus RatingGAN has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $1.97, GAN has an estimated upside of 8.84% from its current price of $1.81.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1.97 representing 100% downside risk from its current price of $1.81.
Fair Value
-
According to the consensus of 2 analysts, GAN has 8.84% upside to fair value with a price target of $1.97 per share.
GAN vs. S&P 500
-
Over the past 5 trading days, GAN has underperformed the S&P 500 by -0.6% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
GAN does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
GAN has grown year-over-year revenues for 3 quarters straight. In the most recent quarter GAN reported revenues of $31.7M.
Earnings Growth
-
GAN has grown year-over-year earnings for 0 quarters straight. In the most recent quarter GAN reported earnings per share of -$0.09.
Enterprise value:
91M
EV / Invested capital:
--
Price / LTM sales:
0.62x
EV / EBIT:
--
EV / Revenue:
0.67x
PEG ratio (5yr expected):
--
EV / Free cash flow:
33.93x
Price / Operating cash flow:
31.20x
Enterprise value / EBITDA:
29.71x
Gross Profit (TTM):
$94.6M
Return On Assets:
-9.71%
Net Income Margin (TTM):
-5.9%
Return On Equity:
-870.33%
Return On Invested Capital:
-21.86%
Operating Margin:
-8.39%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $141.5M | $129.4M | $135M | $30.7M | $31.7M | |
| Gross Profit | $99.9M | $90.7M | $94.6M | $20.9M | $20.7M | |
| Operating Income | -$24.7M | -$30.3M | -$3.6M | -$8.6M | -$2.7M | |
| EBITDA | -$393K | -$13.4M | $3.1M | -$5.4M | -$1.7M | |
| Diluted EPS | -$4.64 | -$0.78 | -$0.18 | -$0.21 | -$0.09 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $163.5M | $54.4M | $67.6M | $56.5M | $52.8M | |
| Total Assets | $173.2M | $260.9M | $103.1M | $87.5M | $77.1M | |
| Current Liabilities | $17.3M | $33M | $32.5M | $36.7M | $31.2M | |
| Total Liabilities | $17.7M | $36.9M | $82.3M | $92.1M | $88.3M | |
| Total Equity | $155.6M | $224M | $20.8M | -$4.6M | -$11.1M | |
| Total Debt | -- | -- | $28.2M | $42.2M | $46.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$1.2M | -$3.6M | $5.8M | $75K | $5.7M | |
| Cash From Investing | -$19.1M | -$6.8M | -$3.1M | -$2M | -$881K | |
| Cash From Financing | $27.4M | $1.3M | $2K | $94K | -$1K | |
| Free Cash Flow | -$20.4M | -$10.4M | $2.7M | -$2M | $4.8M | |
GAN
Sector
Market Cap
$82.9M
$395M
Price % of 52-Week High
95.26%
67.19%
Dividend Yield
0%
0%
Shareholder Yield
--
4.04%
1-Year Price Total Return
52.1%
-17.54%
Beta (5-Year)
3.643
0.786
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$1.79
200-day SMA
Buy
Level
$1.77
Bollinger Bands (100)
Buy
Level
1.75 - 1.85
Chaikin Money Flow
Sell
Level
-36.5M
20-day SMA
Buy
Level
$1.75
Relative Strength Index (RSI14)
Buy
Level
61.46
ADX Line
Buy
Level
18.24
Williams %R
Sell
Level
-9.0909
50-day SMA
Buy
Level
$1.76
MACD (12, 26)
Buy
Level
0.01
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Neutral
Level
33.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-3.3009)
Sell
CA Score
(Annual)
Level (-2.8055)
Buy
Beneish M-Score
(Annual)
Level (-3.688)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (7.2103)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
GAN Ltd provides Software-as-a-Service solutions for online casino gaming and sports betting applications. The company has two operating segments B2B and B2C. The B2B segment develops, markets, and sells instances of GameSTACK, GAN Sports, and iSight Back Office technology that incorporates comprehensive player registration, account funding, and back-office accounting and management tools that enable the casino operators to efficiently, confidently, and effectively extend their presence online in places that have permitted online real money gaming, and The B2C segment, which includes the operations of Coolbet, develops and operates a B2C online sports betting and casino platform that is accessible through its website in markets across Northern Europe, Latin America, and Canada.
Stock Forecast FAQ
In the current month, GAN has received 0 Buy ratings 2 Hold ratings, and 0 Sell ratings. The GAN average analyst price target in the past 3 months is $1.97.
-
Where Will GAN Stock Be In 1 Year?
According to analysts, the consensus estimate is that GAN share price will rise to $1.97 per share over the next 12 months.
-
What Do Analysts Say About GAN?
Analysts are divided on their view about GAN share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that GAN is a Sell and believe this share price will drop from its current level to $1.97.
-
What Is GAN's Price Target?
The price target for GAN over the next 1-year time period is forecast to be $1.97 according to 2 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is GAN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for GAN is a Hold. 2 of 2 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of GAN?
You can purchase shares of GAN via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase GAN shares.
-
What Is The GAN Share Price Today?
GAN was last trading at $1.81 per share. This represents the most recent stock quote for GAN. Yesterday, GAN closed at $1.81 per share.
-
How To Buy GAN Stock Online?
In order to purchase GAN stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is down 0% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 21.54% over the past day.
